Katherine G Young (Katherine Young, Katie G Young)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 21

Top Topics

Ankylosing Spondylitis

Systemic Sclerosis

Glycemic Control

Community Acquired Pneumonia

Top Venues

medRxiv : the preprint server for health sciences

International journal of epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Katie G Young, Katherine G Young, Anand T N Nair, Rhian Hopkins, Andrew P McGovern, Eram Haider, Piyumanga Karunaratne, Louise Donnelly, Bilal A Mateen, Naveed Sattar, Rury R Holman, Jack Bowden, Andrew T Hattersley, Ewan R Pearson, Angus G Jones, Beverley M Shields, Trevelyan J McKinley, Raphael Sonabend, null null
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Diabetologia 67 (5) (2024)
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, James Godwin, Daniyal Raja, Bilal A Mateen, Robert J Challen, Sebastian J Vollmer, Beverley M Shields, Andrew P McGovern, Raphael Sonabend
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study. BMJ open 14 (1) (2024)
Katie G Young, Katherine G Young, Anand T N Nair, Rhian Hopkins, Andrew P McGovern, Eram Haider, Piyumanga Karunaratne, Louise Donnelly, Bilal A Mateen, Naveed Sattar, Rury R Holman, Jack Bowden, Andrew T Hattersley, Ewan R Pearson, Angus G Jones, Beverley M Shields, Trevelyan J McKinley, Raphael Sonabend, null null
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Diabetologia 67 (5) (2024)
Katie G Young, Katherine G Young, Andrew T Hattersley, Beverley M Shields, Angus G Jones, Raphael Sonabend
Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570. Diabetes care 47 (9) (2024)
Katie G Young, Katherine G Young, Anand T N Nair, Rhian Hopkins, Andrew P McGovern, Eram Haider, Piyumanga Karunaratne, Louise Donnelly, Bilal A Mateen, Naveed Sattar, Rury R Holman, Jack Bowden, Andrew T Hattersley, Ewan R Pearson, Angus G Jones, Beverley M Shields, Trevelyan J McKinley, Raphael Sonabend, null null
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Diabetologia 67 (5) (2024)
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, James Godwin, Daniyal Raja, Bilal A Mateen, Robert J Challen, Sebastian J Vollmer, Beverley M Shields, Andrew P McGovern, Raphael Sonabend
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study. BMJ open 14 (1) (2024)
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, James Godwin, Daniyal Raja, Bilal A Mateen, Robert J Challen, Sebastian J Vollmer, Beverley M Shields, Andrew P McGovern, Raphael Sonabend
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study. BMJ open 14 (1) (2024)
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, James Godwin, Daniyal Raja, Bilal A Mateen, Robert J Challen, Sebastian J Vollmer, Beverley M Shields, Andrew P McGovern, Raphael Sonabend
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study. BMJ open 14 (1) (2024)
Katie G Young, Katherine G Young, Anand T N Nair, Rhian Hopkins, Andrew P McGovern, Eram Haider, Piyumanga Karunaratne, Louise Donnelly, Bilal A Mateen, Naveed Sattar, Rury R Holman, Jack Bowden, Andrew T Hattersley, Ewan R Pearson, Angus G Jones, Beverley M Shields, Trevelyan J McKinley, Raphael Sonabend, null null
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Diabetologia 67 (5) (2024)
Katie G Young, Katherine G Young, Anand T N Nair, Rhian Hopkins, Andrew P McGovern, Eram Haider, Piyumanga Karunaratne, Louise Donnelly, Bilal A Mateen, Naveed Sattar, Rury R Holman, Jack Bowden, Andrew T Hattersley, Ewan R Pearson, Angus G Jones, Beverley M Shields, Trevelyan J McKinley, Raphael Sonabend, null null
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Diabetologia (2024)
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, James Godwin, Daniyal Raja, Bilal A Mateen, Robert J Challen, Sebastian J Vollmer, Beverley M Shields, Andrew P McGovern, Raphael Sonabend
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study. BMJ open 14 (1) (2024)
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, James Godwin, Daniyal Raja, Bilal A Mateen, Robert J Challen, Sebastian J Vollmer, Beverley M Shields, Andrew P McGovern, Raphael Sonabend
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study. BMJ open 14 (1) (2024)
Katie G Young, Katherine G Young, Anand T N Nair, Rhian Hopkins, Andrew P McGovern, Eram Haider, Piyumanga Karunaratne, Louise Donnelly, Bilal A Mateen, Naveed Sattar, Rury R Holman, Jack Bowden, Andrew T Hattersley, Ewan R Pearson, Angus G Jones, Beverley M Shields, Trevelyan J McKinley, Raphael Sonabend, null null
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Diabetologia 67 (5) (2024)
Katherine G Young, Eram Haider McInnes, Robert J Massey, Anna R Kahkohska, Scott J Pilla, Sridharan Raghaven, Maggie A Stanislawski, Deirdre K Tobias, Andrew P McGovern, Adem Y Dawed, Angus G Jones, Ewan R Pearson, Raphael Sonabend, null null
Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors. medRxiv : the preprint server for health sciences (2023)
Katherine G Young, Andrew P McGovern, Inês A Barroso, Andrew T Hattersley, Angus G Jones, Beverley M Shields, Nicholas J M Thomas, Raphael Sonabend
HbA 1c screening for the diagnosis of diabetes. Reply to Brož J, Brabec M, Krollová P et al [letter]. Diabetologia (2023)
Katherine G Young, Eram Haider McInnes, Robert J Massey, Anna R Kahkohska, Scott J Pilla, Sridharan Raghaven, Maggie A Stanislawski, Deirdre K Tobias, Andrew P McGovern, Adem Y Dawed, Angus G Jones, Ewan R Pearson, Raphael Sonabend, null null
Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors. medRxiv : the preprint server for health sciences (2023)
Katherine G Young, Eram Haider McInnes, Robert J Massey, Anna R Kahkohska, Scott J Pilla, Sridharan Raghaven, Maggie A Stanislawski, Deirdre K Tobias, Andrew P McGovern, Adem Y Dawed, Angus G Jones, Ewan R Pearson, Raphael Sonabend, null null
Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors. medRxiv : the preprint server for health sciences (2023)
Katherine G Young, Andrew P McGovern, Inês A Barroso, Andrew T Hattersley, Angus G Jones, Beverley M Shields, Nicholas J M Thomas, Raphael Sonabend
Correction to: The impact of population-level HbA 1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis. Diabetologia (2023)
Mark Gilchrist, Francesco Casanova, Jessica Tyrrell, Stuart Cannon, Andrew R Wood, Nicole Fife, Katherine G Young, Richard A Oram, Michael N Weedon
Prevalence of Fabry disease-causing variants in the UK Biobank. Journal of medical genetics (2022)
Katherine G Young, Timothy J McDonald, Beverley M Shields
Glycated haemoglobin measurements from UK Biobank are different to those in linked primary care records: implications for combining biochemistry data from research studies and routine clinical care. International journal of epidemiology 51 (3) (2022)
Katherine G Young, Andrew P McGovern, Inês A Barroso, Andrew T Hattersley, Angus G Jones, Beverley M Shields, Nicholas J M Thomas, Raphael Sonabend
The impact of population-level HbA 1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis. Diabetologia (2022)